Lv3
220 积分 2023-02-01 加入
Angiopoietin-Like 3 Antibody Therapy in Patients With Suboptimally Controlled Hyperlipidemia
3小时前
已完结
Durability and efficacy of solbinsiran, a GalNAc-conjugated siRNA targeting ANGPTL3, in adults with mixed dyslipidaemia (PROLONG-ANG3): a double-blind, randomised, placebo-controlled, phase 2 trial
4小时前
已完结
GLP-1 receptor agonists in patients with chronic kidney disease and either overweight or obesity
2个月前
已关闭
Weight-adjusted-waist index, estimated glucose disposal rate, C-reactive protein, and mortality risks among individuals with type 2 diabetes: two prospective cohort studies in China and the UK
2个月前
已关闭
Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis
3个月前
已完结
2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association
3个月前
已完结
A Real-World Study of Inebilizumab in Patients with Neuromyelitis Optica Spectrum Disorder (P11-8.012)
6个月前
已关闭
A Real-world Study of Inebilizumab for Neuromyelitis Optica Spectrum Disorders (P9-1.008)
6个月前
已关闭
Safety and Lipid-Lowering Efficacy of Inclisiran Monotherapy in Patients without ASCVD: The VICTORION-Mono Randomized Clinical Trial
6个月前
已完结
Lepodisiran — A Long-Duration Small Interfering RNA Targeting Lipoprotein(a)
6个月前
已完结
皖公网安备34019202002308
